- 4500 Park Granada, Suite #202 Calabasas, CA 91302
- Call: 1-800-123-1234
ONC Health IT Costs and Limitation Disclosure:
Our Health IT Module is fully compliant with ONC Certification Criteria and has been certified by an ONC-Authorized Certification Body (ONC-ACB) in accordance with the standards set forth by the Secretary of Health and Human Services. Please note, this certification is not an endorsement by the U.S. Department of Health and Human Services.
At MD Synergy Solutions, LLC, we are committed to fostering transparency and trust in the marketplace. In compliance with 45 CFR 170.523(k)(1), we pledge to provide clear, timely, and accessible information regarding the costs, performance, and business practices of our certified health IT products and services. This information will be made available in the following situations:
-To anyone who requests such information.
– To individuals seeking a quotation, estimate, service description, or other relevant details about MD Synergy Solutions’ certified health IT products.
-To all customers before entering into any agreement for certified health IT products, services, updates, add-ons, or during the course of an ongoing agreement.
Additionally, there are no hidden costs or limitations associated with implementing or using our Certified Health IT to meet meaningful use objectives or achieve any intended use within the certification scope.
Our Health IT Module is fully compliant with ONC Certification Criteria and has been certified by an ONC-Authorized Certification Body (ONC-ACB) in accordance with the standards set forth by the Secretary of Health and Human Services. Please note, this certification is not an endorsement by the U.S. Department of Health and Human Services.
At MD Synergy Solutions, LLC, we are committed to fostering transparency and trust in the marketplace. In compliance with 45 CFR 170.523(k)(1), we pledge to provide clear, timely, and accessible information regarding the costs, performance, and business practices of our certified health IT products and services. This information will be made available in the following situations:
-To anyone who requests such information.
– To individuals seeking a quotation, estimate, service description, or other relevant details about MD Synergy Solutions’ certified health IT products.
-To all customers before entering into any agreement for certified health IT products, services, updates, add-ons, or during the course of an ongoing agreement.
Additionally, there are no hidden costs or limitations associated with implementing or using our Certified Health IT to meet meaningful use objectives or achieve any intended use within the certification scope.
Certified Criteria (170.315) | Subsection | Description |
---|---|---|
170.315 | (a)(1) | Computerized Provider Order Entry (CPOE) – Medications |
170.315 | (a)(2) | CPOE – Laboratory |
170.315 | (a)(3) | CPOE – Diagnostic Imaging |
170.315 | (a)(4) | Drug-Drug, Drug-Allergy Interaction Checks for CPOE |
170.315 | (a)(5) | Demographics |
170.315 | (a)(9) | Clinical Decision Support |
170.315 | (a)(12) | Family Health History |
170.315 | (a)(14) | Implantable Device List |
170.315 | (a)(15) | Social, Psychological, and Behavioral Determinants Data |
170.315 | (b)(1) | Transitions of Care (Cures Update) |
170.315 | (b)(2) | Clinical Information Reconciliation and Incorporation (Cures Update) |
170.315 | (b)(3) | Electronic Prescribing (Cures Update) |
170.315 | (b)(10) | Electronic Health Information Export |
170.315 | (c)(1) | Clinical Quality Measures – Record and Export |
170.315 | (c)(2) | Clinical Quality Measures – Import and Calculate |
170.315 | (c)(3) | Clinical Quality Measures – Report |
170.315 | (d)(1) | Authentication, Access Control, Authorization |
170.315 | (d)(2) | Auditable Events and Tamper-Resistance (Cures Update) |
170.315 | (d)(3) | Audit Report(s) (Cures Update) |
170.315 | (d)(4) | Amendments |
170.315 | (d)(5) | Automatic Access Time-out |
170.315 | (d)(6) | Emergency Access |
170.315 | (d)(7) | End-User Device Encryption |
170.315 | (d)(8) | Integrity |
170.315 | (d)(9) | Trusted Connection |
170.315 | (d)(12) | Encrypt Authentication Credentials (Cures Update) |
170.315 | (d)(13) | Multi-Factor Authentication (Cures Update) |
170.315 | (e)(1) | View, Download, and Transmit to 3rd Party (Cures Update) |
170.315 | (e)(3) | Patient Health Information Capture |
170.315 | (g)(2) | Automated Measure Calculation |
170.315 | (g)(3) | Safety-Enhanced Design |
170.315 | (g)(4) | Quality Management System |
170.315 | (g)(5) | Accessibility-Centered Design |
170.315 | (g)(6) | Consolidated CDA Creation Performance (Cures Update) |
170.315 | (g)(7) | Application Access – Patient Selection |
170.315 | (g)(9) | Application Access – All Data Request (Cures Update) |
170.315 | (g)(10) | Standardized API for Patient and Population Services (Cures Update) |
170.315 | (h)(1) | Direct Project |
Measure ID | Description | Version |
---|---|---|
CMS22 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | v11 |
CMS68 | Documentation of Current Medications in the Medical Record | v12 |
CMS69 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | v11 |
CMS122 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%) | v11 |
CMS125 | Breast Cancer Screening | v11 |
CMS130 | Colorectal Cancer Screening | v11 |
CMS131 | Diabetes: Eye Exam | v11 |
CMS133 | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery | v11 |
CMS135 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | v11 |
CMS138 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | v11 |
CMS139 | Falls: Screening for Future Fall Risk | v11 |
CMS143 | Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation | v11 |
CMS144 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | v11 |
CMS145 | Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) | v11 |
CMS156 | Use of High-Risk Medications in the Elderly | v11 |
CMS165 | Controlling High Blood Pressure | v11 |